DATA COLLECTION METHODOLOGY

Secondary Data Sources

Comprehensive literature review and data mining

PubMed
Biomedical Literature
35M+
FDA
Regulatory Data
15K+
EU
EMA
European Medicines
8K+
WHO
Global Health Data
195
ClinicalTrials.gov
Clinical Trials
450K+
Healthcare Utilization
Data
100+
IQVIA
Market Intelligence
100+
Primary Market Research Capabilities

Robust primary research infrastructure and performance

15,000
Total Expert Interviews (till 2024)
320
Newly Added Interviews (2025)
45+
Countries with Interview Coverage
94%
Interview Completion Rate
98%
Data Quality Score
45min
Average Interview Duration
Expert Network by Specialization

Diverse epidemiological and clinical expert perspectives

KOLs

2200+

Cardiologists Endocrinologists Diabetologists Vascular Surgeons Haematologists Immunologists +21 more
Payers

110+

Regulatory bodies Insurance Providers Pricing & Listing Committees
Health Economist/Market Access Professionals

240+

Market Access Specialists Health Economics Experts Reimbursement Professionals
Clinical Researchers

180+

Principal Investigators Clinical Research Coordinators Research Scientists
Epidemiologists

320+

Population Health Experts Disease Surveillance Specialists Biostatisticians
Industry Experts

230+

Pharmaceutical Executives Medical Affairs Commercial Strategists

Ready to Transform Your Epidemiological Research?

Join industry leaders who trust Epi Lansis for comprehensive pharmaceutical analytics and insights

5500+
Expert Interviews
120+
Indications Covered
50+
Countries Served
Start Free Trial
No credit card required • 14-day free trial • Cancel anytime